General MedicationsORALGeneric

VENLAFAXINE HYDROCHLORIDE

Standard Dose

150MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 078057 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE; ORAL - 150MG Sponsor IMPAX LABS Submission history Latest submission status date: 2007-10-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 078057 (ANDA). Marketing status: None (Tentative Approval) Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE; ORAL - 150MG Sponsor IMPAX LABS Submission history Latest submission status date: 2007-10-16 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.